Hong Kong TV reporter Wu Xiaojun Xiongtuo reports from Chengdu, Sichuan Province
Good Doctor Pharmaceutical Group, the ethnic medicine enterprise from Liangshan area of Sichuan province, has been widely concerned because of the "good doctor" trademark dispute with relevant enterprises. "Economic Information Daily" reporter learned that the Good Doctor Group has adhered to the development of "national brand" as its own responsibility for many years, in-depth development of traditional Chinese medicine industry, has been listed on the top 100 list of China's pharmaceutical industry for 12 consecutive years. Geng Fureng, chairman of the Good Doctor Group, said in an interview with a reporter from the Economic Information Daily that it will continue to build a century-old "good doctor" national brand and effectively promote the sustainable development of the traditional Chinese medicine industry.
Good Doctor Group chairman Geng Funeng
The trademark dispute has come to an end
Regarding the brand dispute between the Good Doctor Group and relevant enterprises, Geng Fueng introduced that the "good Doctor" trademark belongs to the Good Doctor Group and continues to use, we applied for it in accordance with the law on October 19, 1998, and was registered on February 21, 2000, and then approved and renewed by the State Trademark Office in accordance with the provisions. In October 2010, the registered trademark of "good Doctor" was recognized as a national well-known trademark.
It is understood that the trademark dispute between the Good Doctor Group and relevant enterprises lasted about five years. Up to now, more than 50 good doctor trademarks of other enterprises related to medicine and health have been invalid or rejected by judicial and administrative departments. The trademark dispute is now over.
"The brand of the enterprise is not built overnight, it can be formed through years of accumulation and precipitation, and the sustainable development of the industry needs brand enterprises." Geng Funeng believes that at the judicial level, the administrative level and even the whole society should create an atmosphere of brand protection, zero tolerance for infringement of brand rights and damage to the brand development ecology, and fight to the end.
Build a century-old "good doctor" national brand
For the development of the "good Doctor" brand, Geng Fueng said that the Good Doctor Group is a pharmaceutical and health enterprise started from Dliangshan, Sichuan Province, from 1986 to the "Canon Da" brand business, to 1998, according to the law and approved to register the "good Doctor" brand. To now has 37 wholly-owned subsidiaries, 14 GMP pharmaceutical factories, national postdoctoral research workers and provincial academicians (experts) workstation of national high-tech enterprises, national intellectual property demonstration enterprises, national intellectual property management system certification enterprises, And won the "China Pharmaceutical Industry Top 100", "China Private Enterprise Social Responsibility Top 100", "Sichuan Private Enterprise Top 100" and other titles.
According to reports, in recent years, "good doctor" trademark has been registered overseas, in the United States, Japan, Germany and other more than 40 countries under trademark protection. Adhering to the corporate philosophy of "Be a good person and make good medicine", Good Doctor Group has been deeply engaged in the medical and medical industry, and actively fulfilled its social responsibilities, participating in poverty alleviation, rural revitalization, earthquake and flood relief, donating money to students, and anti-epidemic and supply protection during the novel coronavirus epidemic, enjoying high visibility and influence in the industry and society.
"After 37 years of industry experience, Good Doctor Group has developed so far, and we have achieved a compound annual growth rate of 20%." Geng Fumeng said that since 2003, our company has begun to lay out drug retail, medical services and large health industries, and established the brand development road of "focusing on public health and building a century-old dream brand".
Empower primary medical care to take the road of innovation
Brand is the lifeblood of enterprise development. Good Doctor has always highly respected and attached importance to intellectual property rights and brand protection, paid attention to scientific and technological innovation and research and development investment for a long time, integrated intellectual property rights and brands into corporate strategic management, and accumulated a lot of achievements and experience in the field of intellectual property rights and brand protection, from intellectual property rights to enterprises, strong enterprises to brand enabling high-quality development. Good Doctor has always been continuously improving and progressing in the creation, application and protection of intellectual property rights and brands, and its brand value exceeded 43.9 billion yuan in 2022.
It is understood that Good Doctor Group currently has the world's largest American cockroach breeding base, with national/provincial enterprise technology center, provincial engineering technology center, provincial key laboratory, national high-tech enterprise, provincial academician (expert) workstation and national postdoctoral research workstation. In addition, the "scientific Research Headquarters" and "Shennong - Apollo Drug Research Center" were newly established in the past two years, and the products of the Good Doctor rehabilitation new liquid obtained the natural medicine product license issued by the Ministry of Health Canada in the same year, becoming the domestic wound repair traditional Chinese medicine varieties registered successfully in Canada.
At present, Good Doctor Group's innovative research on traditional Chinese medicine has reached the molecular level, and in 2022, two original first-class new drugs have been evaluated clinically. At the same time, Good Doctor Group has also established an industry-university-research platform with a number of domestic universities and research institutes such as Zhejiang University, Sichuan University and University of Macau.
From the perspective of industry and products, under the guidance of adhering to the concept of scientific and technological innovation, the innovative products of Good Doctor Group, such as rehabilitation new liquid, anti-sense granules for children, Sangjiang cold series products, cockling series products, American planeta ground, aconite decoction pieces, pomegranate deep-processing daily chemical and cosmetics, have shown strong market growth momentum with rich scientific research results. According to incomplete statistics, in the past ten years, the Good Doctor Group has accumulated new sales revenue of more than 5 billion yuan, and accumulated indirect economic benefits of more than 10 billion yuan.
"Our good doctor cloud medical, through many years of operation, has fully empowered primary medical care, let high-quality resources sink, and is committed to enjoying the level of medical services and products at the door of the third class hospital, and has hatched four platforms of 'diagnosis Bao Bei', 'Diagnosis professor', 'Yaoyao' and 'good drug optimization'." Geng Fumeng said that up to now, it has served more than 390,000 grassroots clinics and pharmacies. In addition, Good Doctor Cloud Medical has also been recognized by famous medical professional investment institutions in the United States and has completed A round of financing.
In addition to technological innovation, in terms of model innovation, Good Doctor Group has made full efforts to layout Internet medical, build a development pattern of large health industry, and set up "Beijing Good Doctor Cloud Hospital Management Co., LTD.", Good Doctor Cloud Testing Center, Chengdu Good Doctor Medical Testing Center, etc. In addition, through the online operation of good doctor cloud testing, the offline distribution of good doctor national medical chain clinics, and the acquisition of Internet B2B and B2C licenses, Good Doctor Group has developed from the original simple pharmaceutical industry and commerce to fully involved in medical services and Internet medical.